{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T11:05:23Z","timestamp":1785150323991,"version":"3.55.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100014587","name":"Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81771267"],"award-info":[{"award-number":["81771267"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82271344"],"award-info":[{"award-number":["82271344"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["817712673"],"award-info":[{"award-number":["817712673"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.brainres.2024.149284","type":"journal-article","created":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T19:46:21Z","timestamp":1729107981000},"page":"149284","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["2-BFI protects against ischemic stroke by selectively acting on NR2B-containing NMDA receptors"],"prefix":"10.1016","volume":"1845","author":[{"given":"Shasha","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaou","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunfei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiqi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yungang","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peijun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0901-9870","authenticated-orcid":false,"given":"Zhao","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"24","key":"10.1016\/j.brainres.2024.149284_b0005","doi-asserted-by":"crossref","first-page":"6275","DOI":"10.1007\/s00216-020-02477-z","article-title":"In situ metabolite and lipid analysis of GluN2D and wild-type mice after ischemic stroke using MALDI MSI","volume":"412","author":"Andrews","year":"2020","journal-title":"Anal. Bioanal. Chem."},{"issue":"7","key":"10.1016\/j.brainres.2024.149284_b0010","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/S0960-894X(02)00074-4","article-title":"5-Phosphonomethylquinoxalinediones as competitive NMDA receptor antagonists with a preference for the human 1A\/2A, rather than 1A\/2B receptor composition","volume":"12","author":"Auberson","year":"2002","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"4","key":"10.1016\/j.brainres.2024.149284_b0015","article-title":"Current advances in ischemic stroke research and therapies","volume":"1866","author":"Barthels","year":"2020","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.brainres.2024.149284_b0020","doi-asserted-by":"crossref","unstructured":"Ba\u015fkaya M, Rao A, Donaldson D, Prasad M, Dempsey R. Protective effects of ifenprodil on ischemic injury size, blood-brain barrier breakdown, and edema formation in focal cerebral ischemia. Neurosurgery. 1997;40(2):364-70; discussion 70-1. doi: 10.1097\/00006123-199702000-00026. PubMed PMID: 9007871.","DOI":"10.1097\/00006123-199702000-00026"},{"issue":"10","key":"10.1016\/j.brainres.2024.149284_b0025","doi-asserted-by":"crossref","first-page":"e146","DOI":"10.1161\/CIR.0000000000000485","article-title":"Heart disease and stroke statistics-2017 update: a report from the American Heart Association","volume":"135","author":"Benjamin","year":"2017","journal-title":"Circulation"},{"issue":"5443","key":"10.1016\/j.brainres.2024.149284_b0030","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1126\/science.286.5443.1358","article-title":"Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms","volume":"286","author":"Bonni","year":"1999","journal-title":"Science (New York, N.Y.)"},{"issue":"11","key":"10.1016\/j.brainres.2024.149284_b0035","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1161\/STROKEAHA.108.521898","article-title":"Differential roles of NMDA receptor subtypes in ischemic neuronal cell death and ischemic tolerance","volume":"39","author":"Chen","year":"2008","journal-title":"Stroke"},{"issue":"5","key":"10.1016\/j.brainres.2024.149284_b0040","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S0891-5849(01)00819-X","article-title":"Imidazoline drugs stabilize lysosomes and inhibit oxidative cytotoxicity in astrocytes","volume":"32","author":"Choi","year":"2002","journal-title":"Free Radical Biol. Med."},{"issue":"5","key":"10.1016\/j.brainres.2024.149284_b0045","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1093\/emboj\/16.5.998","article-title":"DAP-kinase is a Ca2+\/calmodulin-dependent, cytoskeletal-associated protein kinase, with cell death-inducing functions that depend on its catalytic activity","volume":"16","author":"Cohen","year":"1997","journal-title":"EMBO J."},{"issue":"6","key":"10.1016\/j.brainres.2024.149284_b0050","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00001756-199206000-00004","article-title":"Photochemical stroke and brain-derived neurotrophic factor (BDNF) mRNA expression","volume":"3","author":"Comelli","year":"1992","journal-title":"Neuroreport"},{"issue":"3","key":"10.1016\/j.brainres.2024.149284_b0055","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0959-4388(00)00215-4","article-title":"NMDA receptor subunits: diversity, development and disease","volume":"11","author":"Cull-Candy","year":"2001","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.brainres.2024.149284_b0060","doi-asserted-by":"crossref","unstructured":"Davis S, Albers G, Diener H, Lees K, Norris J. Termination of Acute Stroke Studies Involving Selfotel Treatment. ASSIST Steering Committed. Lancet (London, England). 1997;349(9044):32. doi: 10.1016\/s0140-6736(05)62166-6. PubMed PMID: 8999265.","DOI":"10.1016\/S0140-6736(05)62166-6"},{"issue":"6","key":"10.1016\/j.brainres.2024.149284_b0065","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19061635","article-title":"Extension of Tissue Plasminogen Activator Treatment Window by Granulocyte-Colony Stimulating Factor in a Thromboembolic Rat Model of Stroke","volume":"19","author":"Dela Pe\u00f1a","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.brainres.2024.149284_b0070","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1002\/jnr.24574","article-title":"Roles of GluN2C in cerebral ischemia: GluN2C expressed in different cell types plays different role in ischemic damage","volume":"98","author":"Ding","year":"2020","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.brainres.2024.149284_b0075","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1749-6632.1995.tb32388.x","article-title":"I1-imidazoline receptors. Definition, characterization, distribution, and transmembrane signaling","volume":"763","author":"Ernsberger","year":"1995","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"10","key":"10.1016\/j.brainres.2024.149284_b0080","first-page":"1171","article-title":"NMDA-stimulated expression of BDNF mRNA in cultured cerebellar granule neurones","volume":"4","author":"Favaron","year":"1993","journal-title":"Neuroreport"},{"issue":"4","key":"10.1016\/j.brainres.2024.149284_b0085","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1161\/01.STR.26.4.602","article-title":"Safety and tolerability of the glutamate antagonist CGS 19755 (Selfotel) in patients with acute ischemic stroke. Results of a phase IIa randomized trial","volume":"26","author":"Grotta","year":"1995","journal-title":"Stroke"},{"issue":"4","key":"10.1016\/j.brainres.2024.149284_b0090","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1179\/174313209X444116","article-title":"Attenuation of ischemia-induced rat brain injury by 2-(-2-benzofuranyl)-2-imidazoline, a high selectivity ligand for imidazoline I(2) receptors","volume":"31","author":"Han","year":"2009","journal-title":"Neurol. Res."},{"key":"10.1016\/j.brainres.2024.149284_b0095","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.brainres.2010.09.029","article-title":"2-(-2-benzofuranyl)-2-imidazoline induces Bcl-2 expression and provides neuroprotection against transient cerebral ischemia in rats","volume":"1361","author":"Han","year":"2010","journal-title":"Brain Res."},{"issue":"3","key":"10.1016\/j.brainres.2024.149284_b0100","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.bbrc.2012.06.152","article-title":"Neurovascular protection conferred by 2-BFI treatment during rat cerebral ischemia","volume":"424","author":"Han","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"5","key":"10.1016\/j.brainres.2024.149284_b0105","doi-asserted-by":"crossref","first-page":"e64894","DOI":"10.1371\/journal.pone.0064894","article-title":"Fast, non-competitive and reversible inhibition of NMDA-activated currents by 2-BFI confers neuroprotection","volume":"8","author":"Han","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.brainres.2024.149284_b0110","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.nbd.2004.03.013","article-title":"Mechanisms leading to disseminated apoptosis following NMDA receptor blockade in the developing rat brain","volume":"16","author":"Hansen","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.brainres.2024.149284_b0115","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1042\/BST0371147","article-title":"Coupling of the NMDA receptor to neuroprotective and neurodestructive events","volume":"37","author":"Hardingham","year":"2009","journal-title":"Biochem. Soc. Trans."},{"issue":"5","key":"10.1016\/j.brainres.2024.149284_b0120","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/nn835","article-title":"Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways","volume":"5","author":"Hardingham","year":"2002","journal-title":"Nat. Neurosci."},{"issue":"8","key":"10.1016\/j.brainres.2024.149284_b0125","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1523\/JNEUROSCI.4485-05.2006","article-title":"Calpain-cleaved collapsin response mediator protein-3 induces neuronal death after glutamate toxicity and cerebral ischemia","volume":"26","author":"Hou","year":"2006","journal-title":"J. Neurosci.: Off. J. Soc. Neurosci."},{"issue":"4","key":"10.1016\/j.brainres.2024.149284_b0130","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/sj.onc.1201172","article-title":"DAP-kinase loss of expression in various carcinoma and B-cell lymphoma cell lines: possible implications for role as tumor suppressor gene","volume":"15","author":"Kissil","year":"1997","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.brainres.2024.149284_b0135","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00441-006-0273-6","article-title":"NMDA receptor function: subunit composition versus spatial distribution","volume":"326","author":"K\u00f6hr","year":"2006","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.brainres.2024.149284_b0140","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ejphar.2011.07.041","article-title":"Morphine-induced antinociception in the rat: supra-additive interactions with imidazoline I2 receptor ligands","volume":"669","author":"Li","year":"2011","journal-title":"Eur. J. Pharmacol."},{"issue":"1\u20133","key":"10.1016\/j.brainres.2024.149284_b0145","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0014-2999(96)00131-8","article-title":"[3H] 2-(2-benzofuranyl)-2-imidazoline: a new selective high affinity radioligand for the study of rabbit brain imidazoline I2 receptors","volume":"304","author":"Lione","year":"1996","journal-title":"Eur. J. Pharmacol."},{"issue":"11","key":"10.1016\/j.brainres.2024.149284_b0150","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1523\/JNEUROSCI.0116-07.2007","article-title":"NMDA receptor subunits have differential roles in mediating excitotoxic neuronal death both in vitro and in vivo","volume":"27","author":"Liu","year":"2007","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.brainres.2024.149284_b0155","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1161\/01.STR.20.1.84","article-title":"Reversible middle cerebral artery occlusion without craniectomy in rats","volume":"20","author":"Longa","year":"1989","journal-title":"Stroke"},{"key":"10.1016\/j.brainres.2024.149284_b0160","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.brainres.2011.03.011","article-title":"The neuroprotective effects of NMDAR antagonist, ifenprodil and ASIC1a inhibitor, flurbiprofen on post-ischemic cerebral injury","volume":"1389","author":"Mishra","year":"2011","journal-title":"Brain Res."},{"issue":"3","key":"10.1016\/j.brainres.2024.149284_b0165","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/0896-6273(94)90210-0","article-title":"Developmental and regional expression in the rat brain and functional properties of four NMDA receptors","volume":"12","author":"Monyer","year":"1994","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.brainres.2024.149284_b0170","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0165-6147(96)81564-1","article-title":"The elusive family of imidazoline binding sites","volume":"17","author":"Parini","year":"1996","journal-title":"Trends Pharmacol. Sci."},{"issue":"1","key":"10.1016\/j.brainres.2024.149284_b0175","first-page":"29","article-title":"Psychopharmacology of imidazoline and alpha 2-adrenergic receptors: implications for depression","volume":"9","author":"Piletz","year":"1994","journal-title":"Crit. Rev. Neurobiol."},{"issue":"26","key":"10.1016\/j.brainres.2024.149284_b0180","doi-asserted-by":"crossref","first-page":"24923","DOI":"10.1074\/jbc.M413915200","article-title":"Subunit assembly of N-methyl-d-aspartate receptors analyzed by fluorescence resonance energy transfer","volume":"280","author":"Qiu","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.brainres.2024.149284_b0185","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/jnr.490340611","article-title":"Expression of non-adrenergic imidazoline sites in rat cerebral cortical astrocytes","volume":"34","author":"Regunathan","year":"1993","journal-title":"J. Neurosci. Res."},{"issue":"51","key":"10.1016\/j.brainres.2024.149284_b0190","doi-asserted-by":"crossref","first-page":"42290","DOI":"10.1074\/jbc.M505804200","article-title":"Death-associated protein kinase is activated by dephosphorylation in response to cerebral ischemia","volume":"280","author":"Shamloo","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"50","key":"10.1016\/j.brainres.2024.149284_b0195","doi-asserted-by":"crossref","first-page":"47460","DOI":"10.1074\/jbc.M105133200","article-title":"The pro-apoptotic function of death-associated protein kinase is controlled by a unique inhibitory autophosphorylation-based mechanism","volume":"276","author":"Shohat","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.brainres.2024.149284_b0200","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0896-6273(00)81010-7","article-title":"Ca2+ influx regulates BDNF transcription by a CREB family transcription factor-dependent mechanism","volume":"20","author":"Tao","year":"1998","journal-title":"Neuron"},{"issue":"8","key":"10.1016\/j.brainres.2024.149284_b0205","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1038\/jcbfm.2010.18","article-title":"Activation of NR2A receptors induces ischemic tolerance through CREB signaling","volume":"30","author":"Terasaki","year":"2010","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"1","key":"10.1016\/j.brainres.2024.149284_b0210","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0021-9258(18)52415-7","article-title":"Subcellular distribution of imidazoline-guanidinium-receptive sites in human and rabbit liver. Major localization to the mitochondrial outer membrane","volume":"266","author":"Tesson","year":"1991","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.brainres.2024.149284_b0215","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0014-2999(92)90316-V","article-title":"Tissue-specific localization of mitochondrial imidazoline-guanidinium receptive sites","volume":"219","author":"Tesson","year":"1992","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.brainres.2024.149284_b0220","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.ejphar.2011.09.173","article-title":"Effects of imidazoline I2 receptor ligands on morphine- and tramadol-induced antinociception in rats","volume":"670","author":"Thorn","year":"2011","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.brainres.2024.149284_b0225","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3233\/JIN-170032","article-title":"2-(2-benzofuranyl)-2-imidazoline (2-BFI) improved the impairments in AD rat models by inhibiting oxidative stress, inflammation and apoptosis","volume":"16","author":"Tian","year":"2017","journal-title":"Journal of Integrative Neuroscience."},{"issue":"12","key":"10.1016\/j.brainres.2024.149284_b0230","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1111\/ene.13450","article-title":"Intravenous thrombolysis for patients with in-hospital stroke onset: propensity-matched analysis from the Safe Implementation of Treatments in Stroke-East registry","volume":"24","author":"Tsivgoulis","year":"2017","journal-title":"Eur. J. Neurol."},{"issue":"2","key":"10.1016\/j.brainres.2024.149284_b0235","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.cell.2009.12.055","article-title":"DAPK1 interaction with NMDA receptor NR2B subunits mediates brain damage in stroke","volume":"140","author":"Tu","year":"2010","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.brainres.2024.149284_b0240","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.bbrc.2011.02.018","article-title":"2-BFI attenuates experimental autoimmune encephalomyelitis-induced spinal cord injury with enhanced B-CK, CaATPase, but reduced calpain activity","volume":"406","author":"Wang","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4","key":"10.1016\/j.brainres.2024.149284_b0245","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S0026-895X(25)13275-6","article-title":"Ifenprodil discriminates subtypes of the N-methyl-D-aspartate receptor: selectivity and mechanisms at recombinant heteromeric receptors","volume":"44","author":"Williams","year":"1993","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.brainres.2024.149284_b0255","doi-asserted-by":"crossref","first-page":"801","DOI":"10.3389\/fphar.2020.00801","article-title":"Combined Treatment With 2-(2-Benzofu-Ranyl)-2-Imidazoline and Recombinant Tissue Plasminogen Activator Protects Blood-Brain Barrier Integrity in a Rat Model of Embolic Middle Cerebral Artery Occlusion","volume":"11","author":"Zhang","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"6","key":"10.1016\/j.brainres.2024.149284_b0260","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/j.jstrokecerebrovasdis.2017.12.041","article-title":"2-(2-Benzofuranyl)-2-imidazoline mediates neuroprotection by regulating the neurovascular unit integrity in a rat model of focal cerebral ischemia","volume":"27","author":"Zhang","year":"2018","journal-title":"J. Stroke Cerebrovasc. Dis."}],"container-title":["Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899324005389?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899324005389?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T23:49:03Z","timestamp":1783122543000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006899324005389"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":51,"alternative-id":["S0006899324005389"],"URL":"https:\/\/doi.org\/10.1016\/j.brainres.2024.149284","relation":{},"ISSN":["0006-8993"],"issn-type":[{"value":"0006-8993","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"2-BFI protects against ischemic stroke by selectively acting on NR2B-containing NMDA receptors","name":"articletitle","label":"Article Title"},{"value":"Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainres.2024.149284","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"149284"}}